Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture or metformin for insulin resistance in women with polycystic ovary syndrome
2015-004250-18Phase 2Active
- Sponsor
- Karolinska Institutet
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of metformin in polycystic ovary syndrome (PCOS) and insulin resistance (IR) (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Change in insulin sensitivity by HOMA-IR, Change in insulin response during OGTT and 1 more. Started Nov 2015; status: active.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)insulin resistance (IR)
Beyond the preview
Go deeper on 2015-004250-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004250-18.